Transcription of Imfinzi Full Prescribing Information
{{id}} {{{paragraph}}}
Example: dental hygienist
Imfinzi Full Prescribing Information
US-56097 HIGHLIGHTS OF Prescribing INFORMATIONT hese highlights do not include all the Information needed to use Imfinzi safely and effectively. See full Prescribing Information for (durvalumab) injection, for intravenous use Initial Approval: 2017--------------------------------- RECENT MAJOR CHANGES--------------------------------- Indications and Usage, Urothelial Carcinoma Accelerated ApprovalIndication Removed (1) 02/2021 Dosage and Administration ( ) 02/2021 Dosage and Administration, Dosage Modifications ( ) 11/2020 Dosage and Administration ( ) 07/2021 Warnings and Precautions ( , ) 11/2020 Warnings and Precautions ( ) 07/2021--------------------------------- INDICATIONS AND USAGE --------------------------------- Imfinzi is a programmed death-ligand 1 (PD-L1) blocking antibody indicated.
Monitor for early identification and management. Evaluate liver enzymes, ... Administer infusion solution intravenously over 60 minutes through an intravenous line containing a sterile, low-protein binding 0.2 or 0.22 micron in-line filter. • Do not co-administer other drugs through the …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: